ARVIND REMEDIES LIMITED
			UNAUDITED FINANCIAL RESULTS
			FOR THE QUARTER AND NINE MONHTS ENDED DECEMBER 31, 2006
								(Rupees in Lakhs.)
			Particulars	Three months ended 31.12.2006	Three months ended 31.12.2005	Corresponding nine months ended 31.12.2006	Corresponding nine months ended 31.12.2005	Year ended 31.3.2006
				Unaudited	Unaudited	Unaudited	Unaudited	Audited
			Gross Sales	4317.59	3592.96	12,906.27	12,286.75	16,507.79
			Less: Excise Duty	(519.85)	(420.07)	(1,612.12)	(1,553.78)	(2,117.19)
			Net Sales	3,797.74	3,172.89	11,294.15	10,732.97	14,390.60
			Other Income	4.90	17.97	16.37	57.92	66.10
			Total Income	3,802.64	3,190.86	11,310.52	10,790.89	14,456.70
			Total expenditure :
			a)  (Increase) / Decrease in Stock	(69.58)	155.58	31.30	66.09	423.05
			b)  Materials Consumed	3175.94	2473.91	9,471.37	8,985.37	12,012.64
			c)  Staff Cost	90.23	79.35	249.97	230.78	293.97
			d)  Other expenditure	233.21	245.98	465.10	560.25	597.78
			Total (a) to (d)	3,429.80	2,954.82	10,217.74	9,842.49	13,327.44
			Gross Profit before Interest & Depreciation	372.84	236.04	1,092.78	948.40	1,129.26
			Interest	158.54	86.78	426.07	333.57	476.20
			Depreciation	44.19	37.36	127.14	113.64	151.25
			Profit before Tax	170.11	111.90	539.57	501.19	501.81
			Provision for Taxation
			Income Tax (Including Fringe Benefit Tax)	26.13	20.00	66.13	80.00	92.00
			Earlier years	-	8.97	0.12	9.87	18.57
			Deferred Tax	62.13	(16.81)	41.02	(27.35)	84.13
			Wealth Tax					0.26
			Profit / (Loss) after Tax	81.85	99.74	432.30	438.67	306.85
			Paid-up Equity Share Capital	2600.50	2600.50	2600.50	2600.50	2600.50
			(face value Re. 1/- per Share)
			Reserves excluding Revaluation Reserve	-	-	-	-	1,234.95
			Basic and Diluted Earnings Per Share (Rs.)	0.03	0.04	0.17	0.17	0.12
			Aggregate of Non-Promoter Shareholding
			Number of shares	194205340	194205340	194205340	194205340	194205340
			Percentage of Shareholding	74.68%	74.68%	74.68%	74.68%	74.68%
			Note :
			1. The Company operates only in one business segment namely  formulations.
			2. Previous period's figures have been regrouped / rearranged  wherever necessary to confirm to the current periods classification.
			3. Provision for taxation for the nine months ended December 31, 2006 has been made on an estimate basis.  The actual tax liability will be determined on the basis of
			the taxable income of the Company for the year from April 1, 2006 to March 31, 2007.
			4. The above results were reviewed by the audit committee and taken on record at the meeting of the Board of Directors held on February 26, 2007.
			5. During the quarter 26 investor complaints were received and disposed off.  There were no investor complaints pending for the redressal as at the
			the commencement and end of the quarter.
			6. The above results for the quarter and nine months ended December 31, 2006 have been subjected to a Limited Review by the statutory auditors as per the listing agreement
			with the stock exchanges.
			Chennai - 600 084				For ARVIND REMEDIES LTD.
			Date: February 26, 2007
							Dr. B Arvind Shah
							CEO and Managing Director